US2018303813A1PendingUtilityA1

Sublingual fentanyl spray

64
Assignee: INSYS DEV CO INCPriority: Jan 25, 2006Filed: Jun 27, 2018Published: Oct 25, 2018
Est. expiryJan 25, 2026(expired)· nominal 20-yr term from priority
A61P 43/00A61P 35/00A61P 29/00A61P 25/04A61P 25/20A61P 23/00A61K 9/006A61K 31/4468A61M 11/00A61K 31/435A61K 31/445A61K 47/10A61K 9/0056
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A sublingual formulation comprising from about 0.1% to about 0.9% by weight fentanyl, a free base or a pharmaceutically acceptable salt thereof, or a derivative thereof, from about 20% to about 60% by weight ethanol and from about 4% to about 6% by weight propylene glycol. 
     
     
         2 . The composition of  claim 1 , wherein ethanol is at a concentration from about 50% to about 60%. 
     
     
         3 . A method of treating pain comprising administering a formulation of  claim 1 . 
     
     
         4 . The method of  claim 3 , wherein the pain is breakthrough pain.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.